Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.46 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.46 |
| ▸ | CHRNG | P07510 | 1/20 | 0.46 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.46 |
| ▸ | CHRND | Q07001 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.45 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424183 | 0.94 | MMP2 (0.61) | MMP2OPRM1OPRD1CHRNA1CHRNG | |
| SCHEMBL7586807 | 0.88 | OPRD1 (0.55) | MMP2OPRM1OPRD1CHRNA1CHRNG | |
| SCHEMBL7586788 | 0.88 | OPRD1 (0.55) | MMP2OPRM1OPRD1CHRNA1CHRNG | |
| SCHEMBL30478748 | 0.88 | MMP2 (0.55) | MMP2CHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL30903442 | 0.88 | OPRM1 (0.48) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29679605 | 0.88 | MMP2 (0.52) | MMP2OPRM1OPRD1CHRNA1CHRNG | |
| SCHEMBL30179375 | 0.88 | MMP2 (0.58) | MMP2OPRK1 | |
| SCHEMBL10523181 | 0.87 | MMP2 (0.60) | MMP2OPRM1OPRD1CHRNA1CHRNG | |
| SCHEMBL31759049 | 0.87 | MMP2 (0.53) | MMP2OPRM1OPRD1OPRK1 | |
| SCHEMBL29737836 | 0.86 | NMT1 (0.45) | MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |